During the past decade, Hamburger Institut für Therapieforschung GmbH (HIT) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hamburger Institut für Therapieforschung GmbH (HIT)" #1 collaborator was "Hannover Medical School" with 2 trials as a collaborator, "Philipps University Marburg Medical Center" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "German Center for Lung Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hamburger Institut für Therapieforschung GmbH (HIT)" are "Asthma" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Chronic Obstructive Pulmonary Disease (COPD)" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Hamburger Institut für Therapieforschung GmbH (HIT)" in a lesser frequency.

Most popular intervention types in "Hamburger Institut für Therapieforschung GmbH (HIT)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Tiotropium + olodaterol" (1 trials), "placebo" (1 trials) and "risankizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hamburger Institut für Therapieforschung GmbH (HIT)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hamburger Institut für Therapieforschung GmbH (HIT)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Hamburger Institut für Therapieforschung GmbH (HIT), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hamburger Institut für Therapieforschung GmbH (HIT), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".